Detailed Information on Publication Record
2008
Epidemiology of Gastrointestinal Cancers
GERYK, Edvard, Petr DÍTĚ and Milan KONEČNÝBasic information
Original name
Epidemiology of Gastrointestinal Cancers
Name in Czech
Epidemiologický vývoj gastrointestinálních nádorů
Name (in English)
Epidemiology of Gastrointestinal Cancers
Authors
GERYK, Edvard (203 Czech Republic, guarantor), Petr DÍTĚ (203 Czech Republic) and Milan KONEČNÝ (203 Czech Republic)
Edition
Tallin, Gastrosymposium Tallin, p. 12-12, 1 pp. 2008
Publisher
University of Tallin
Other information
Language
Czech
Type of outcome
Stať ve sborníku
Field of Study
30200 3.2 Clinical medicine
Country of publisher
Czech Republic
Confidentiality degree
není předmětem státního či obchodního tajemství
RIV identification code
RIV/00216224:14310/08:00025192
Organization unit
Faculty of Science
ISBN
80-902266-9-8
Keywords in English
cancer; stomach; intestine; epidemiology
Tags
Tags
International impact
Změněno: 21/4/2010 15:39, prof. RNDr. Milan Konečný, CSc.
V originále
During 14 years colorectal cancers in the productive age of 35-64 years increased by 6.2% in mortality, by 44.7% in incidence and by 100,8% in prevalence. In prediction is estimated about 5.500 surviving cancers of stomach, 32,000 of colon, 24,000 of rectum, 1700 of gallbladder and 1400 of pankreas. The new diagnosed gastrointestinal cancers were characterised by very unfavourable relations of early and advantage stages. The higher mortality of advantage and uncertain stages rises the numbers of early stages in prevalence and also the expenditure of health insurance system in oncology.
In English
During 14 years colorectal cancers in the productive age of 35-64 years increased by 6.2% in mortality, by 44.7% in incidence and by 100,8% in prevalence. In prediction is estimated about 5.500 surviving cancers of stomach, 32,000 of colon, 24,000 of rectum, 1700 of gallbladder and 1400 of pankreas. The new diagnosed gastrointestinal cancers were characterised by very unfavourable relations of early and advantage stages. The higher mortality of advantage and uncertain stages rises the numbers of early stages in prevalence and also the expenditure of health insurance system in oncology.
Links
| GA205/07/1278, research and development project |
| ||
| 2E08028, research and development project |
|